A072201: Randomized Phase II Trial of Anti-LAG-3 and Anti-PD-1 Blockade vs SOC in Patients with Recurrent Glioblastoma
- Title
- Randomized Phase II Trial of Anti-LAG-3 and Anti-PD-1 Blockade vs SOC in Patients with Recurrent Glioblastoma
- Principal Investigator
- Aulakh, Sonikpreet
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Brain Cancer
- Participating Institutions
- Camden Clark Medical Center
- Mary Babb Randolph Cancer Center
- Contacts
- Nina Moore, RN
- Research Specialist
- Phone: +1 304-293-2991
- Email: nina.moore@hsc.wvu.edu
- Maher Kali, MD
- Clinical Research Specialist-WVUCI
- Phone: +1 304-243-7045
- Email: maher.kali@wvumedicine.org
- Layla Tannoury
- Clinical Research Specialist
- Phone: +1 304-424-2585
- Email: layla.tannoury@wvumedicine.org